Utilization patterns and determinants of guideline-recommended therapies for acute heart failure in Denmark

Heart Failure

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Eur J Heart Fail

Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C

doi: 10.1002/ejhf.3565

Heart Failure

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Fail

Schjødt I, Valentin JB, Johnsen SP, Mols RE, Egstrup K, Løgstrup BB

doi: 10.1002/ehf2.15320

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart Failure

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Eur J Heart Fail

Gorenek B, Wijnmaalen AP, Goette A, Mert GO, Porter B, Gustafsson F, Dan GA, Ector J, Stuehlinger M, Spartalis M, Gosau N, Amir O, Chioncel O

doi: 10.1002/ejhf.3645

Heart Failure

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Eur J Heart Fail

Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G

doi: 10.1002/ejhf.3719

Heart Failure

Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease

J Am Heart Assoc

Zemke AM, Zelnick LR, Ix JH, Go AS, Siew ED, Bansal N

doi: 10.1161/JAHA.124.039868

Heart Failure

Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure

J Am Heart Assoc

Wettersten N, Duff S, Horiuchi Y, van Veldhuisen DJ, Estrella MM, Shlipak MG, Maisel A, Murray PT, Ix JH

doi: 10.1161/JAHA.125.042880

Heart Failure

Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission

ESC Heart Fail

Möckel M, Pudasaini S, Feldmann K, Baberg HT, Levenson B, Malzahn J, Mansky T, Michels G, Günster C, Jeschke E

doi: 10.1002/ehf2.15280

Heart Failure

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

ESC Heart Fail

Berry NC, Sheu YS, Chesbrough K, Bishop RC, Vupputuri S

doi: 10.1002/ehf2.15193

Related content

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure

Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease

Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure

Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort